UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  November 9, 2015

 

URANIUM RESOURCES, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

001-33404

 

75-2212772

(State or Other Jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification No.)

 

6950 S. Potomac Street, Suite 300
Centennial, Colorado

 

80112

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (303) 531-0470

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 




 

Item 2.02   Results of Operations and Financial Condition.

 

On November 9, 2015, Uranium Resources, Inc. (the “Company”) issued a press release relating to its results for the third quarter of 2015.  A copy of the press release is furnished herewith as Exhibit 99.1.

 

The information in this Current Report on Form 8-K under Item 2.02, including the accompanying press release, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by reference to such filing.

 

Item 7.01  Regulation FD Disclosure.


 On November 9, 2015, the Company issued a press release announcing that it had entered into a binding letter of intent for the sale of its Churchrock and Crownpoint properties in New Mexico to Laramide Resources Limited. The full text of the press release is furnished with this Form 8-K as Exhibit 99.2 and incorporated by reference herein.

 

The information in this Current Report on Form 8-K under Item 7.01, including the accompanying press release, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by reference to such filing.


Item 8.01  Other Events.


URI is providing an updated list of material subsidiaries as Exhibit 21.1 hereto. As previously disclosed, on June 3, 2015, the Company, entered into a scheme implementation agreement with Anatolia Energy Limited, an Australian public company (“Anatolia”), pursuant to which URI acquired all of the outstanding equity of Anatolia (the “Merger”) on November 9, 2015. The updated list of material subsidiaries includes Anatolia and its material subsidiaries.


Attached as Exhibits 4.1-4.12 are forms of certain options and performance shares issued to holders of certain interests in Anatolia in connection with the closing of the Merger.


Item 9.01  Financial Statements and Exhibits.

 

(d)           Exhibits.

 

Exhibit No.

 

Description

4.1

 

Form of options expiring June 15, 2017.

4.2

 

Form of options expiring November 28, 2018.

4.3

 

Form of options expiring October 8, 2019.

4.4

 

Form of options expiring September 30, 2016.

4.5

 

Form of options expiring November 30, 2017.

4.6

 

Form of options expiring November 30, 2017.

4.7

 

Form of options expiring January 20, 2020.

4.8

 

Form of options expiring February 28, 2019.

4.9

 

Form of options expiring March 2, 2018.

4.10

 

Form of options expiring March 6, 2017.

4.11

 

Form of options expiring June 30, 2019.

4.12

 

Form of class A performance shares.

21.1

 

Subsidiaries of the Registrant.

99.1

 

Press Release dated November 9, 2015 relating to third quarter results.

99.2

 

Press Release dated November 9, 2015 relating to sale of non-core assets.





 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 13, 2015

 

 

URANIUM RESOURCES, INC.

 

 

 

 

 

By:

/s/ Jeffrey L. Vigil

 

Name:

Jeffrey L. Vigil

 

Title:

Vice President—Finance and Chief Financial Officer



















 

Exhibit Index



Exhibit No.

 

Description

4.1

 

Form of options expiring June 15, 2017.

4.2

 

Form of options expiring November 28, 2018.

4.3

 

Form of options expiring October 8, 2019.

4.4

 

Form of options expiring September 30, 2016.

4.5

 

Form of options expiring November 30, 2017.

4.6

 

Form of options expiring November 30, 2017.

4.7

 

Form of options expiring January 20, 2020.

4.8

 

Form of options expiring February 28, 2019.

4.9

 

Form of options expiring March 2, 2018.

4.10

 

Form of options expiring March 6, 2017.

4.11

 

Form of options expiring June 30, 2019.

4.12

 

Form of class A performance shares.

21.1

 

Subsidiaries of the Registrant.

99.1

 

Press Release dated November 9, 2015 relating to third quarter results.

99.2

 

Press Release dated November 9, 2015 relating to sale of non-core assets.










[EX41002.GIF]




APPLICATION FORM ON EXERCISE OF OPTIONS EXPIRING 15 JUNE 2017

To the Directors, Uranium Resources, Inc.

I/We hereby exercise                                                      option(s) and hand you herewith my/our cheque for                                    


Being US$2.08 per share on application for                                                         shares in the capital of the Company (in the form of CHESS Depository Interests).


I/We request that you allot me that number of shares (in the form of CHESS Depository Interests) and I/we agree to accept that number of shares (in the form of CHESS Depository Interests) on the terms below and the Certificate of Incorporation and Bylaws of the Company, and I/we authorise you to place my/our name on the register.

My/Our SRN/HIN (as shown on my/our Issuer Sponsored holding statement or CHESS           ______________________

Holdings statement)


Sign Here – This section must be signed for your instructions to be executed

I/We authorize you to act in accordance with my/our instructions set out above

   Individual or Securityholder

Securityholder 2

Securityholder 3


________________________________

Director


___________________________

Director/Company Secretary


_______________________________

Sole Director and
Sole Company Secretary


Note: when signed under Power of Attorney, the attorney states that they have not received a notice of revocation. Computershare needs to sight a certified copy of the Power of Attorney

Day/Date

Month

Year


Contact Name

_____________________________


Contact Telephone

______________________________



                   /                        /



Terms and

Conditions of

Options Overleaf







[EX41004.GIF]


TERMS AND CONDITIONS OF THE OPTIONS EXPIRING 15 JUNE 2017



The Attaching Options ( New Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares (in the form of CHESS Depository Interests) ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each New Option gives the Optionholder the right to subscribe for one Share.

(b)

The New Options will expire at 5.00pm (WST) on 15 June 2017 ( Expiry Date ). Any New Option not exercised before the Expiry Date will automatically lapse.

(c)

The amount payable upon exercise of each New Option is US$2.08 ( Exercise Price ).

(d)

The New Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(e)

An Optionholder may exercise their New Options by lodging with the Company, before the Expiry Date:

(i)

a written notice of exercise of New Options specifying the number of New Options being exercised ( Exercise Notice ); and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of New Options being exercised.

(f)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(g)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of New Options specified in the Exercise Notice.

(h)

All Shares allotted upon the exercise of New Options will upon allotment rank pari passu in all respects with other Shares.

(i)

Subject to the satisfaction of the requirements of the ASX Listing Rules, the Company will apply for quotation of the New Options (in the form of Chess Depositary Interests or otherwise) on ASX.

(j)

The Company will apply for quotation of all Shares  allotted pursuant to the exercise of New Options on ASX within 10 Business Days after the date of allotment of those Shares.

(k)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(l)

There are no participating rights or entitlements inherent in the New Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the New Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their New Options prior to the date for determining entitlements to participate in any such issue.

(m)

A New Option does not confer the right to a change in exercise price or a change in the number of underlying securities over which the New Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the New Options may (or if no exemption from registration under the United States Securities Act of 1933, as amended, is available and the holder desires to exercise the New Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in





[EX41004.GIF]


TERMS AND CONDITIONS OF THE OPTIONS EXPIRING 15 JUNE 2017



which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their New Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the New Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their New Options (or portion thereof if a partial exercise) in accordance with the terms of the New Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States (in the form of shares of common stock or otherwise), the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States (in the form of Chess Depositary Interests or otherwise), the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the New Options shall be deemed amended such that they comply with such United States laws.


LODGEMENT INSTRUCTIONS

Cheques shall be in the currency of the United States of America made payable to Uranium Resources, Inc. and crossed “Not Negotiable”. The application for shares on exercise of the options with the appropriate remittance should be lodged at Uranium Resources, Inc., 6950 South Potomac Street, Suite 300, Centennial, Colorado USA 80112.




[EX42002.GIF]


TERMS AND CONDITIONS OF US$0.58 INCENTIVE OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Date/s );

 

PROPORTION OF OPTIONS ISSUED

VESTING DATE

i.

50%

Immediately on issue

ii..

25%

29 May 2014

iii.

25%

29 November 2014

(c)

The Options will expire at 5:00pm (WST) on 28 November 2018 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (k), the amount payable upon exercise of each Option will be US$0.58 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise the Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of  the Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised for ( Exercise Notice );

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of the Options will upon allotment rank pari passu in all respects with other common shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of the Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and an Optionholder will not be entitled to participate in new issues of capital offered to shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 business days after the issue is announced. This will give an Optionholder the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the attaching Options can be exercised.





[EX42002.GIF]


TERMS AND CONDITIONS OF US$0.58 INCENTIVE OPTIONS




(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX43002.GIF]


TERMS AND CONDITIONS OF US$1.39 OPTIONS EXPIRY 8 OCTOBER 2019



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Dates );

 

PROPORTION OF OPTIONS
ISSUED

VESTING DATE

I.

50%

Immediately on issue

II.

25%

8 April 2015

III.

25%

8 October 2015

(c)

Each Option will expire at 5:00pm (WST) on 8 October 2019 (Expiry Date). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$1.39 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice ).

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares issued upon the exercise of Options will upon issue rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares issued pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of issue of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options

(n)

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(o)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the





[EX43002.GIF]


TERMS AND CONDITIONS OF US$1.39 OPTIONS EXPIRY 8 OCTOBER 2019



issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(p)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX44002.GIF]


TERMS AND CONDITIONS OF US$1.39 OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

Each Option will expire at 5:00pm (WST) on 30 September 2016 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(c)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$1.39 ( Exercise Price ).

(d)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(e)

An Optionholder may exercise their Options by lodging with the Company, before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice ).

(f)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(g)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, issue the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(h)

Subject to the expiry of any applicable escrow period the Options shall be freely transferable.

(i)

All Shares issued upon the exercise of Options will upon issue rank pari passu in all respects with other Shares.

(j)

The Company will not apply for quotation of the Options on ASX. In addition, the Company will also apply for quotation of all Shares issued pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise)  within 10 Business Days after the date of issue of those Shares.

(k)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(l)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options without exercising the Options.

(m)

An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 





[EX44002.GIF]


TERMS AND CONDITIONS OF US$1.39 OPTIONS



(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.




[EX45002.GIF]


TERMS AND CONDITIONS OF MDA OPTIONS



The common stock purchase options ( MDA Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each MDA Option gives the Optionholder the right to subscribe for one Share.

(b)

Each MDA Option will expire at 5:00pm (WST) on 30 November 2017 ( Expiry Date ). An MDA Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(c)

Subject to paragraph (k), the amount payable upon exercise of each MDA Option will be US$0.92 ( Exercise Price ).

(d)

The MDA Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(e)

An Optionholder may exercise their MDA Options by lodging with the Company, before the Expiry Date:

(i)

a written notice of exercise of MDA Options specifying the number of MDA Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of MDA Options being exercised ( Exercise Notice ).

(f)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(g)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of MDA Options specified in the Exercise Notice.

(h)

The MDA Options are not transferable except with the prior written consent of the board of directors of the Company.

(i)

All Shares allotted upon the exercise of MDA Options will upon allotment rank pari passu in all respects with other Shares.

(j)

The Company will not apply for quotation of the MDA Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of MDA Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(k)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(l)

There are no participating rights or entitlements inherent in the MDA Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the MDA Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their MDA Options prior to the date for determining entitlements to participate in any such issue.

(m)

An MDA Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the MDA Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the MDA Option, must) be exercised, in whole or in part, at such time by means of a “cashless





[EX45002.GIF]


TERMS AND CONDITIONS OF MDA OPTIONS



exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their MDA Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the MDA Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their MDA Options (or portion thereof if a partial exercise) in accordance with the terms of the MDA Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the MDA Options shall be deemed amended such that they comply with such United States laws.




[EX46002.GIF]


TERMS AND CONDITIONS OF MDB OPTIONS



The common stock purchase options ( MDB Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each MDB Option gives the Optionholder the right to subscribe for one Share.

(b)

The MDB Options will vest as follows:

(i)

50% on the date that shareholders approve the grant;

(ii)

25% on 1 August 2013; and

(iii)

25% on 1 August 2014.

(c)

Each MDB Option will expire at 5:00pm (WST) on 30 November 2017 ( Expiry Date ). An MDB Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each MDB Option will be US$0.75 ( Exercise Price ).

(e)

The MDB Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their MDB Options by lodging with the Company, before the Expiry Date:

(i)

a written notice of exercise of MDB Options specifying the number of MDB Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of MDB Options being exercised ( Exercise Notice ).

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of MDB Options specified in the Exercise Notice.

(i)

The MDB Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of MDB Options will upon allotment rank pari passu in all respects with other Shares.

(k)

The Company will not apply for quotation of the MDB Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of MDB Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the MDB Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the MDB Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their MDB Options prior to the date for determining entitlements to participate in any such issue.

(n)

An MDB Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.





[EX46002.GIF]


TERMS AND CONDITIONS OF MDB OPTIONS



(o)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the MDB Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the MDB Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their MDB Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the MDB Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their MDB Options (or portion thereof if a partial exercise) in accordance with the terms of the MDB Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(p)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the MDB Options shall be deemed amended such that they comply with such United States laws.




[EX47002.GIF]


TERMS AND CONDITIONS OF US$0.92 OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Date/s );

 

Proportion of Options Issued

Vesting Date

i.

100%

20 January 2016

(c)

Each Option will expire at 5:00pm (WST) on 20 January 2020 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$0.92 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice );

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of Options will upon allotment rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.





[EX47002.GIF]


TERMS AND CONDITIONS OF US$0.92 OPTIONS



(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX48002.GIF]


TERMS AND CONDITIONS OF US$1.04 OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Date/s );

 

PROPORTION OF OPTIONS ISSUED

VESTING DATE

i.

100%

28 February 2016

(c)

Each Option will expire at 5:00pm (WST) on 28 February 2019 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$1.04 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice );

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of Options will upon allotment rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise





[EX48002.GIF]


TERMS AND CONDITIONS OF US$1.04 OPTIONS



the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX49002.GIF]


TERMS AND CONDITIONS OF US$1.04 INCENTIVE OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Date/s );

 

PROPORTION OF OPTIONS ISSUED

VESTING DATE

i.

100%

2 March 2016

(c)

Each Option will expire at 5.00pm (WST) on 2 March 2018 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$1.04 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice ).

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of Options will upon allotment rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise





[EX49002.GIF]


TERMS AND CONDITIONS OF US$1.04 INCENTIVE OPTIONS



the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX410002.GIF]


TERMS AND CONDITIONS OF US$0.92 INCENTIVE OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows (Vesting Date/s);

 

PROPORTION OF OPTIONS ISSUED

VESTING DATE

i.

100%

6 March 2015

(c)

Each Option will expire at 5.00pm (WST) on 6 March 2017 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$0.92 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice ).

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of Options will upon allotment rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration





[EX410002.GIF]


TERMS AND CONDITIONS OF US$0.92 INCENTIVE OPTIONS



under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must) be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.




[EX411002.GIF]


TERMS AND CONDITIONS OF US$1.04 INCENTIVE OPTIONS



The common stock purchase options ( Options ) entitle the holder thereof ( Optionholder ) to subscribe for certain common shares ( Shares ) of Uranium Resources, Inc. ( Company ) on the following terms and conditions:

(a)

Each Option gives the Optionholder the right to subscribe for one Share.

(b)

The Options will vest as follows ( Vesting Date/s );

 

PROPORTION OF OPTIONS ISSUED

VESTING DATE

i.

100%

Immediately

(c)

Each Option will expire at 5:00pm (WST) on 30 June 2019 ( Expiry Date ). An Option not exercised before the Expiry Date will automatically lapse on the Expiry Date.

(d)

Subject to paragraph (l), the amount payable upon exercise of each Option will be US$1.04 ( Exercise Price ).

(e)

The Options held by each Optionholder may be exercised in whole or in part, and if exercised in part, multiples of 100 must be exercised on each occasion.

(f)

An Optionholder may exercise their Options by lodging with the Company, after the relevant Vesting Date but before the Expiry Date:

(i)

a written notice of exercise of Options specifying the number of Options being exercised; and

(ii)

a cheque or electronic funds transfer for the Exercise Price for the number of Options being exercised ( Exercise Notice ).

(g)

An Exercise Notice is only effective when the Company has received the full amount of the Exercise Price in cleared funds.

(h)

Within 10 Business Days of receipt of the Exercise Notice accompanied by the Exercise Price, the Company will, subject to compliance with all applicable laws and regulations, allot the number of Shares required under these terms and conditions in respect of the number of Options specified in the Exercise Notice.

(i)

The Options are not transferable except with the prior written consent of the board of directors of the Company.

(j)

All Shares allotted upon the exercise of Options will upon allotment rank pari passu in all respects with other ordinary Shares on issue.

(k)

The Company will not apply for quotation of the Options on ASX. However, the Company will apply for quotation of all Shares allotted pursuant to the exercise of Options on ASX (in the form of Chess Depositary Interests or otherwise) within 10 Business Days after the date of allotment of those Shares.

(l)

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Rules at the time of the reconstruction.

(m)

There are no participating rights or entitlements inherent in the Options and Optionholders will not be entitled to participate in new issues of capital offered to Shareholders during the currency of the Options. However, the Company will ensure that for the purposes of determining entitlements to any such issue, the record date will be at least 7 Business Days after the issue is announced. This will give Optionholders the opportunity to exercise their Options prior to the date for determining entitlements to participate in any such issue. An Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Attaching Option can be exercised.

(n)

If at the time of exercise hereof there is no effective registration statement registering under the United States Securities Act of 1933, as amended, or the prospectus contained therein is not available for the





[EX411002.GIF]


TERMS AND CONDITIONS OF US$1.04 INCENTIVE OPTIONS



issuance of the Shares to the Optionholder, then the Options may (or if no exemption from registration under the United States Securities Act of 1933 (as amended) is available, and the holder desires to exercise the Option, must)  be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Optionholder shall be entitled to receive a number of Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =

the VWAP on the trading day immediately preceding the date on which an Optionholder elects to exercise their Options by means of a “cashless exercise,” as set forth in the applicable Exercise Notice;

 

(B) =

the Exercise Price of the Options, as adjusted hereunder; and

 

(X) =

the number of Shares that would be issuable upon exercise of their Options (or portion thereof if a partial exercise) in accordance with the terms of the Options if such exercise were by means of a cash exercise rather than a cashless exercise.

 

VWAP ” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Shares are then listed or quoted on a national securities exchange in the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the national securities exchange on which the Shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Shares are then listed or quoted on a trading market outside of the United States, the daily volume weighted average price of the Shares for such date (or the nearest preceding date) on the trading market on which the Shares are then listed or quoted (and the trading market with the highest volume for such date if the Shares are listed on more than one trading market outside of the United States) as reported by a reporting system determined to be reasonably acceptable by the Company in good faith, (c) if the Shares are not then listed or quoted for trading on a trading market and if prices for the Shares are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported, or (d) in all other cases, the fair market value of a share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Company’s common stock then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.


(o)

In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or an Optionholder, the laws of the United States shall prevail and these terms of the Options shall be deemed amended such that they comply with such United States laws.





[EX412002.GIF]


TERMS AND CONDITIONS OF A CLASS PERFORMANCE SHARES
OF URANIUM RESOURCES, INC.



The terms of the A Class Performance Shares are as follows:


(a)

( Shares ) An A Class Performance Share is a share in the capital of Uranium Resources, Inc. (“ Company ”).

(b)

( General Meeting ) An A Class Performance Share confers on the holder of it (" Holder ") the right to receive notices of meetings and financial reports and accounts of the Company that are circulated to the Company’s stockholders. The Holder has the right to attend meetings of the Company’s stockholders.

(c)

( No Voting Rights ) An A Class Performance Share does not entitle the Holder to vote on any resolutions proposed at a meeting of the Company’s stockholders.

(d)

( No Dividend Rights ) An A Class Performance Share does not entitle the Holder to any dividends.

(e)

( No Rights on Winding Up ) An A Class Performance Share does not confer on the Holder any right to participate in the surplus profits or assets of the Company upon winding up of the Company.

(f)

( Not Transferable ) An A Class Performance Share is not transferable, except that an A Class Performance Share may be distributed or transferred to those persons who were registered as shareholders of Aldridge Uranium Limited (Aldridge) on the record date for determining entitlements to the A Class Performance Shares (Record Date) under the proposed scheme of arrangement transaction involving Aldridge and Anatolia Energy Limited, in proportion to their Aldridge shareholding on the Record Date.

(g)

( Reorganisation of Capital ) If at any time the issued capital of the Company is reconstructed, an A Class Performance Share may be treated in accordance with the ASX Listing Rules at the time of reorganisation.

(h)

( Application to ASX ) A Class Performance Shares will not be quoted on ASX. However, upon conversion of an A Class Performance Share, the Company must within seven (7) days after the conversion, apply for the official quotation of the Shares (in the form of Chess Depositary Interests or otherwise) arising from the conversion on ASX.

(i)

( No Other Rights ) An A Class Performance Share gives the Holder no rights other than those expressly provided by these terms and those provided at law where such rights at law cannot be excluded by these terms.

(j)

( Conflict with US Law ) In the event of any conflict between (x) these terms, or matters of law incorporated herein, and (y) any United States federal or state law or regulation, including United States securities laws, applicable to the Company, its affiliates, or a Holder, the laws of the United States shall prevail and these terms of the A Class Performance Share shall be deemed amended such that they comply with such United States laws.

Conversion of A Class Performance Shares

(a)

( Conversion ) If the Project is found to have a JORC Code compliant resource estimate of in excess of 18 million pounds but less than 20 million pounds of contained U 3 0 8 , all of the A Class Performance Shares on issue will automatically convert to a total of 233,146 Shares for each 1 million pounds of contained U 3 0 8 in that resource estimate ( Performance Hurdle ) in excess of 18 million pounds (such that each A Class Performance Share will convert to 0.0199403 Shares for each 1 million pounds of contained U 3 0 8 in that resource estimate in excess of 18 million pounds) (the calculation being illustrated in Schedule 6 Part B attached to the Scheme Agreement), with a fraction of a Share to which a Holder is entitled being rounded up or down to zero or 1 (whichever is nearer) and 0.5 being rounded up to one Share.

(b)

( Frequency of Conversion ) Conversion will be made on achievement of each of the Performance Hurdles (as per (a), above). The maximum number of Shares which have yet to be converted on an A Class Performance Share at any given time is that number of Performance Hurdles previously achieved for which Shares have been issued deducted from 5 and multiplied by 0.0199403.





[EX412002.GIF]


TERMS AND CONDITIONS OF A CLASS PERFORMANCE SHARES
OF URANIUM RESOURCES, INC.



(c)

( Conversion Procedure ) Upon conversion of the A Class Performance Shares the Company will issue each Holder with a new holding statement for the relevant number of Shares.

(d)

( Ranking of ordinary shares ) The Shares into which the A Class Performance Shares convert will rank pari passu in all respects with existing Shares.

(e)

( Lapse ) If the A Class Performance Shares have not otherwise been converted to Shares by the date which is 5 years after the date of their original issue, those A Class Performance Shares held by each Holder will automatically be forfeited and may then be cancelled by resolution at a general meeting pursuant to section 258D of the Corporations Act or equivalent action under the laws of the State of Delaware.

In this Schedule 1, the following definitions apply:

Aldridge Options means an option to subscribe for an AUI Share that is on issue on the date of this agreement (details of all of such options being as set out in Schedule 9 of the Scheme Agreement).

AUI means Aldridge Uranium Ltd.

AUI Share means a fully paid ordinary share in the capital of AUI.

Company means Uranium Resources, Inc.

Earn-in Period has the meaning given to that term in the Scheme Agreement.

Joint Venture has the meaning given to that term in the Scheme Agreement.

Project has the meaning given to that term in the Scheme Agreement.

Scheme Agreement means the "Scheme of Arrangement Implementation and Farm-In Joint Venture Agreement" entered into by AWH Corporation Ltd. on or about 3 March 2010 pursuant to which AWH Corporation Ltd. may acquire up to a 75% shareholding in AUI.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a holder of a Share.



Exhibit 21.1

URANIUM RESOURCES, INC.

Subsidiaries of the Registrant


Subsidiary Name

Jurisdiction

Ownership

Anatolia Resources Limited

Australia

100% by Uranium Resources, Inc.

Anatolia Uranium (BVI) Ltd

British Virgin Islands

100% by Anatolia Resources Limited

Constellres Ltd

Cyprus

100% by Anatolia Resources Limited

Anatolia Uranium Pty Ltd

Australia

35% by Anatolia Energy Limited; 65% by Anatolia Uranium (BVI) Limited

Mozawl Mining

Mauritius

80% by Anatolia Resources Limited

Adur Madencilik Limited STI

Turkey

100% by Anatolia Uranium Pty Ltd

URI, Inc.

Delaware

100% by Uranium Resources, Inc.

Hydro Resources, Inc. (d/b/a HRI, Energy, Inc.)

Delaware

100% by URI, Inc.

URI Minerals, Inc.

Delaware

100% by Uranium Resources, Inc.

Hydro Restoration Corporation

Delaware

100% by Uranium Resources, Inc.

Belt Line Resources, Inc.

Texas

100% by Uranium Resources, Inc.

Uranco, Inc.

Delaware

100% by Uranium Resources, Inc.

HRI-Churchrock, Inc.

Delaware

100% by Uranium Resources, Inc.

URI Neutron Holdings I, Inc.

Delaware

100% by Uranium Resources, Inc.

URI Neutron Holdings II, Inc.

Delaware

100% by URI Neutron Holdings I, Inc.

Neutron Energy, Inc.

Nevada

100% by URI Neutron Holdings II, Inc.

Cibola Resources LLC

Delaware

100% by Neutron Energy, Inc.










Exhibit 99.1

[EX991002.GIF]


URI Reports Net Income for Third Quarter


CENTENNIAL, Colo., November 9, 2015 – Uranium Resources, Inc. (Nasdaq: URRE; URI) closed the strategic and transformational merger (Merger) with Anatolia Energy Limited (Anatolia) on November 9, 2015. URI has commenced a formal update to the February 2015 Temrezli Pre-Feasibility Study, which is expected to be completed in early 2016.

·

With the merger with Anatolia now complete, URI is actively progressing the high-grade, low-cost Temrezli in-situ recovery (ISR) Project towards production in Central Turkey. The successful development of this near-term project will put URI on the path to profitable uranium production, which URI believes will be well-timed to take advantage of the favorable outlook for uranium.

·

URI’s engineering and design team has made significant progress on planning and logistics for relocation of our Rosita facility’s processing equipment and satellite ion exchange units for use at the Temrezli Project.

·

Subsequent to the end of the third quarter, URI executed a Binding Letter of Intent (LOI) for the sale of its Churchrock and Crownpoint projects in New Mexico to Laramide Resources Ltd. (TSX:LAM) for $12.5 million, contingent on Laramide’s expected financing initiative. For further detail on this transaction, please refer to the Company’s news release issued earlier today.

·

Due to the gain from the sale of the Roca Honda assets in New Mexico of $4.9 million and after recording operating expenses and interest expense, URI reported net income of $305,000 or $0.01 per share for 3Q 2015 compared with a net loss of $(3.99) million or $(0.16) per share for 3Q 2014.


Christopher M. Jones, President and Chief Executive Officer of URI said, “URI has commenced a new chapter in its 38 year history through this transformational Merger with Anatolia. Our goal is to create the next low-cost uranium ISR producer, beginning with the high-margin Temrezli Project in Central Turkey. URI’s highest priority is to advance the high-grade Temrezli in-situ recovery project into commercial production as quickly and efficiently as possible.”

Business Highlights for the Third Quarter:

·

URI and Anatolia shareholders both overwhelmingly approved the merger of the two companies, including the issuance of URI common shares to effect the combination. Former Anatolia shareholders now own approximately 41% of the newly combined company, with the remainder being held by existing URI shareholders.

·

URI received $2.5 million cash, 76,455 Energy Fuels’ shares (NYSE MKT: UUUU) and other consideration on closing of the sale of its non-core assets in the Roca Honda area of New Mexico to Energy Fuels Inc. as announced in URI’s news release on August 3, 2015.

·

Net cash used in operating activities was $2.65 million in 3Q 2015 compared with $2.87 million in 3Q 2014.

Third Quarter and Nine-Month Review

After expenses and recording of a gain of $4.9 million, including a cash gain of $2.5 million, for the sale of the Roca Honda assets, URI reported net income of $305,000 for the 3Q 2015 compared with a net loss of $(3.99) million for 3Q 2014. URI had a net loss of $(8.0) million for the first nine months of 2015, a 24% improvement against the larger net loss of $(10.58) million for the first nine months of 2014.




Excluding non-cash stock compensation, URI’s cash expenditures for general and administrative costs and mineral property expenses were $3.6 million in 3Q 2015, 40% higher than 3Q 2014, and $9.6 million in the first nine months of 2015, slightly higher than the $8.9 million total for the first nine months of 2014. The increase for the third quarter on a year-over-year basis was driven mostly by increased general and administrative costs largely due to the merger costs and $193,000 for the evaluation and acquisition of historic data for the Butler Ranch properties as described in the Company’s news release of July 7, 2015. In addition, the lower recorded expenditures in 3Q 2014 were due to the payment of $342,000 in non-cash stock payment for a property lease.

The Company’s total shares outstanding are now 50.5 million, pending the issuance of the shares for the payment of certain transaction fees.

Balance Sheet and Liquidity Update

The Company ended the third quarter with cash and cash equivalents of $3.8 million. URI believes its current cash balance is sufficient to provide liquidity to fund its current operations through the end of 2015. Upon closing of the sale of Churchrock and Crownpoint projects, URI expects to receive cash of $5.25 million and an additional $7.25 million to follow over the next three years, not including interest. While this cash injection will enhance URI’s balance sheet and while URI continues to have access to additional funding through its At-The-Market agreement to sell common stock, under which there is approximately $6.0 million available, the Company expects it will need to raise additional funding. In addition, URI continues to evaluate post-Merger financing options, including those involving the Temrezli Project.

Tables 1 and 2: Financial Summaries (unaudited)

($ in 000)

Sept 30, 2015

June 30, 2015

March 31, 2015

Dec. 31, 2014

Cash and Cash Equivalents

$3,836

$4,485

$8,381

$5,570

Current Assets

6,239

6,031

9,437

6,433

Current Liabilities

3,946

2,806

2,645

2,672

Working Capital

2,293

3,225

6,792

3,761

Total Assets

44,802

42,546

46,023

43,104

Convertible Loan

8,000

8,000

8,000

8,000

Total Shareholders' Equity

$29,921

$29,357

$33,571

$31,137


($ and Shares in 000, Except Per Share and Uranium Price)

First Nine Months 2015

3Q 2015

2Q 2015

1Q 2015

First Nine Months 2014

3Q 2014

2Q 2014

1Q 2014

First Nine Months Variance

3Q YOY Variance

Net Cash Used in Operations

$(8,481)

$(2,646)

$(3,136)

$(2,699)

$(9,648)

$(2,865)

$(3,033)

$(3,749)

-12%

-8%

Mineral Property Expenses

3,021

920

1,292

809

2,929

987

1,062

880

3%

-7%

General and Administrative, including Non-cash Stock Compensation

7,352

2,851

2,406

2,095

7,002

2,202

2,157

2,642

5%

29%

Non-Cash Interest & Fees Incurred on Convertible Loan

522

180

161

181

513

200

175

138

2%

-10%

Net Income/(Loss)

$(8,008)

$305

$(4,552)

$(3,761)

$(10,583)

$(3,993)

$(3,128)

$(3,460)

-24%

-108%

Net Income/(Loss) Per Share

$(0.28)

$0.01

$(0.15)

$(0.14)

$(0.44)

$(0.16)

$(0.13)

$(0.15)

-36%

-106%

Avg. Weighted Shares Outstanding

28,799

30,010

29,794

26,555

23,987

24,954

24,619

22,359

20%

20%

Uranium Average Weekly Spot Price for the Period (source: UxC)

$37.08

$36.48

$37.41

$37.95

$31.99

$31.17

$29.65

$35.15

16%

17%

Uranium Long-term Price at Period End (source: UxC)

$47.00

$44.00

$46.00

$49.00

$46.11

$44.33

$45.00

$47.00

2%

-1%


Outlook

URI’s 2015 goals outlined below remain unchanged:

·

Achieve zero lost time incidents,

·

Complete and evaluate drill results from the phase one exploration drilling programs at Butler Ranch and Alta Mesa Este projects in South Texas,

·

Establish the scope and timing for phase two exploration programs,

·

Achieve the targeted cash expenditure level of $9.0 million, excluding the transaction costs for the Merger, Anatolia’s operating costs post-merger and other transactions, and

·

Increase shareholder value by adding to our portfolio of quality mineralized material and pursuing opportunistic, value-accretive acquisitions and partnering opportunities.




About Uranium Resources

Uranium Resources, Inc. (URI) is focused on advancing to near-term production the Temrezli in-situ recovery (ISR) project in Central Turkey. URI also controls extensive exploration properties under nine exploration and operating licenses covering approximately 44,700 acres (over 18,000 ha) with numerous exploration targets, including the potential satellite Sefaatli Project, which is 25 miles (40 km) southwest of the Temrezli Project. In Texas, the Company has two licensed and currently idled processing facilities and approximately 17,000 acres (6,900 ha) of prospective ISR projects. In New Mexico, controls minerals rights encompassing approximately 186,000 acres (73,500 ha) in the prolific Grants Mineral Belt in New Mexico, which holds one of the largest known concentrations of sandstone-hosted uranium deposits in the world. Incorporated in 1977, URI also owns an extensive uranium information database of historic drill hole logs, assay certificates, maps and technical reports for the Western United States.

Cautionary Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," and other similar words. All statements addressing operating performance, events or developments that the Company expects or anticipates will occur in the future, including but not limited to statements relating to the proposed transaction between URI and Laramide, including entry into and the terms and conditions of definitive documentation and the timing of definitive documentation and closing, the benefits of the combination with Anatolia Energy, the timing, occurrence or cost of production at the Company’s properties, including the timing of construction, permits and initial production at the Temrezli Project, the timing and conclusions of the updated technical report and economic analysis at the Temrezli Project, the potential relocation of the Rosita plant to Turkey, the availability of financing to the Company, and the achievement of URI’s 2015 goals are forward-looking statements. are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties include, but are not limited to, (a) the Company's ability to raise additional capital in the future; (b) spot price and long-term contract price of uranium; (c) the Company's ability to reach agreements with current royalty holders; (d) operating conditions at the Company's projects; (e) government and tribal regulation of the uranium industry and the nuclear power industry; (f) world-wide uranium supply and demand; (g) maintaining sufficient financial assurance in the form of sufficiently collateralized surety instruments; (h) unanticipated geological, processing, regulatory and legal or other problems the Company may encounter, including in Turkey; (i) the ability of the Company to enter into and successfully close acquisitions or other material transactions, including the proposed transaction with Laramide, and other factors which are more fully described in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company's forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this news release.

Competent Person

Technical information in this release as well as references to mineral resources in Texas and New Mexico are based on information compiled by Dean T. “Ted” Wilton (CPG-7659), who is Chief Geologist and Vice President of URI, and a Qualified Person under Canada National Instrument 43-101. Mr. Wilton is a Professional Geologist in the State of Wyoming and is a Certified Professional Geologist by the American Institute of Professional Geologists a Recognized Overseas Professional Organization (ROPO) as listed by the ASX. Mr. Wilton has over 40 years of minerals industry experience, including more than 5 years of experience that are relevant to the style of mineralization and type of deposit under consideration. He is a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves”. Mr. Wilton consents to the inclusion in this release of the matters based on their information in the form and context in which it appears.

Uranium Resources Contacts :

Wendy Yang
303-531-0478
www.uraniumresources.com


Robert Winters, Alpha IR Group
929-266-6315
robert.winters@alpha-ir.com




Exhibit 99.2

[EX992002.GIF]


Uranium Resources to Raise $12.5 Million from Non-Core Asset Sales

 

CENTENNIAL, Colo., November 9, 2015 – Uranium Resources, Inc. (NASDAQ:URRE; ASX: URI) announced today that it has entered into a Binding Letter of Intent (LOI) for the sale of its Churchrock and Crownpoint properties in New Mexico to Laramide Resources Limited (TSX: LAM; ASX: LAM).


Under the LOI, Uranium Resources (URI) and its subsidiaries have agreed, subject to the execution of definitive documentation, to transfer ownership of URI’s Churchrock and Crownpoint properties to Laramide Resources or its subsidiaries (LAM). URI will receive the following consideration from LAM at closing:


·

$5.25 million in cash;

·

$7.25 million promissory note, secured by a deed of trust or mortgage over the properties. The Note has a 3-year term and carries an initial interest rate of 5% which then increases to 10% when Laramide makes a commercial production decision on Churchrock.  Principal payments of $2.42 million are due and payable on the anniversary of the closing of the proposed transaction in each of 2017, 2018 and 2019.  Interest will be payable on a quarterly basis; provided, however, that no interest will be payable prior to the first principal payment in 2017; and

·

Assumption of any liabilities for remediation on the subject lands by Laramide.  


This sale of the Churchrock and Crownpoint properties continues URI’s proactive M&A strategy, with the sale representing URI’s second asset monetization transaction in 2015. While maintaining a very significant inventory of non-reserve mineralized material which provides the foundation for its future production growth, URI is focused on improving its portfolio alignment with its production experience and expertise in In-Situ Recovery of uranium, targeting operations that fit into the lowest quartile of operating costs.  


The proceeds from this sale to Laramide will significantly strengthen the financial position of URI, and assist in funding development of the high-grade, low-cost Temrezli ISR Project in Central Turkey.  URI is progressing towards production at the project, subject to receipt of all project permits and completion of development financing.  


The significant steps URI has taken in 2015 to realign is project portfolio towards lowest quartile cost assets, including this most recent sale to Laramide, have put the company on a clear path for the future, which coincides favorably with the widely forecast positive outlook for uranium.  


Definitive documentation on the terms above is expected to be executed by the end of 2015, with closing anticipated by late Q1 2016, subject to customary conditions, including applicable stock exchange approvals, regulatory approvals for the transfer of the projects to Laramide, and Laramide raising the capital required to close the transaction.

 

Christopher M. Jones, President and Chief Executive Officer of Uranium Resources, said,


We are pleased to have worked with Laramide to achieve this strategic transaction for our respective shareholders. With the significant royalties that Laramide already own over the Churchrock Project, this transaction makes a great deal of sense for both companies, and importantly for URI, raises new capital to apply to the progression of the Temrezli Project in a non-dilutive manner.



1 of 3




“We have a clear focus in moving towards near-term, low-cost uranium production using ISR production methods and this transaction will significantly strengthen our financial position as we accelerate down this path.   We are very excited about our just completed merger with Anatolia Energy Ltd. and work is already underway for the relocation of our Rosita processing plant from Texas to Turkey, which will provide significant costs capital costs savings in the development of this world-class ISR project .”   


URI and Laramide are working together towards a timely execution of definitive documentation and all approvals required in respect of the transaction, including the transfer of URI’s NRC licence as it pertains to the sale properties. It is expected that the transaction will close in late Q1 2016.


About Uranium Resources  

 

Uranium Resources, Inc. (URI) is focused on advancing to near-term production the Temrezli in-situ recovery (ISR) project in Central Turkey. URI also controls extensive exploration properties under nine exploration and operating licenses covering approximately 44,700 acres (over 18,000 ha) with numerous exploration targets, including the potential satellite Sefaatli Project, which is 25 miles (40 km) southwest of the Temrezli Project. In Texas, the Company has two licensed and currently idled processing facilities and approximately 17,000 acres (6,900 ha) of prospective ISR projects. In New Mexico, the Company controls minerals rights encompassing approximately 186,000 acres (75,300 ha) in the prolific Grants Mineral Belt in New Mexico, which holds one of the largest concentrations of sandstone-hosted uranium deposits in the world. Incorporated in 1977, URI also owns an extensive uranium information database of historic drill hole logs, assay certificates, maps and technical reports for the Western United States.  


Cautionary Statement  


This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," and other similar words. All statements addressing operating performance, events or developments that the Company expects or anticipates will occur in the future, including but not limited to statements relating to the proposed transaction between URI and Laramide, including entry into and the terms and conditions of definitive documentation and the timing of definitive documentation and closing, the benefits of the combination with Anatolia Energy, the timing, occurrence or cost of production at the Company’s properties, including the timing of construction, permits and initial production at the Temrezli Project, the timing and conclusions of the updated technical report and economic analysis at the Temrezli Project, the potential relocation of the Rosita plant to Turkey, and the availability of financing to the Company are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties.  These risk factors and uncertainties include, but are not limited to, (a) the Company's ability to raise additional capital in the future; (b) spot price and long-term contract price of uranium; (c) the Company's ability to reach agreements with current royalty holders; (d) operating conditions at the Company's projects; (e) government and tribal regulation of the uranium industry and the nuclear power industry; (f) world-wide uranium supply and demand; (g) maintaining sufficient financial assurance in the form of sufficiently collateralized surety instruments; (h) unanticipated geological, processing, regulatory and legal or other problems the Company may encounter, including in Turkey; (i) the ability of the Company to enter into and successfully close acquisitions or other material transactions, including the proposed transaction with Laramide, and other factors which are more fully described in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company's forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this news release.



2 of 3




Competent Person  


Technical information in this release as well as references to mineral resources in Texas and New Mexico are based on information compiled by Dean T. “Ted” Wilton (CPG-7659), who is Chief Geologist and Vice President of URI, and a Qualified Person under Canada National Instrument 43-101. Mr. Wilton is a Professional  Geologist  in  the  State  of  Wyoming  and  is  a Certified Professional Geologist by  the American Institute of Professional Geologists a Recognized Overseas  Professional Organization (ROPO)  as  listed  by  the  ASX.  Mr. Wilton has over 40 years of minerals industry experience, including more than 5 years of experience that are relevant to the style of mineralization and type of deposit under consideration. He is a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves”. Mr. Wilton consents to the inclusion in this release of the matters based on their information in the form and context in which it appears.  


Uranium Resources Contacts :  


Wendy Yang  

Robert Winters, Alpha IR Group

303-531-0478

929-266-6315

 

www.uraniumresources.com  

robert.winters@alpha-ir.com

 

 

 



3 of 3